Intensity Therapeutics Stock (NASDAQ: INTS) stock price, news, charts, stock research, profile.
You can purchase shares of Intensity Therapeutics (NASDAQ:INTS) through any online brokerage.
Other companies in Intensity Therapeutics’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Serina Therapeutics (AMEX:SER), Fortress Biotech (NASDAQ:FBIO), Gain Therapeutics (NASDAQ:GANX) and OncoCyte (NASDAQ:OCX).
Intensity Therapeutics has a consensus price target of $8.50.
The stock price for Intensity Therapeutics (NASDAQ: INTS) is $2.95 last updated November 20, 2024 at 3:55 PM EST.
There are no upcoming dividends for Intensity Therapeutics.
Intensity Therapeutics’s Q3 earnings are confirmed for Wednesday, November 13, 2024.
There is no upcoming split for Intensity Therapeutics.
Intensity Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.